October 15-16 2018, Logroño
Consortium gathered together in Logroño (Spain) the 15th and 16th of October to discuss the project progress and the coming milestones for the next 6 months.
The device prototype was set up in the CIBIR premises by Technion partners and FRS (Alfredo’s Group) will be in charge of testing it with cell culture, mouse models expressing breast cancer and ultimately clinical samples from patients suffering this disease.
Local governors and press also attended the event. They published articles about the HYPOSENS project and the involvement of the local partner, CIBIR.
